Nanotechnology News – Latest Headlines

Exotic phases on an atom chip

The realization of topological insulators with cold atoms is extremely attractive, as it would offer an ideal quantum spin Hall effect within a laboratory. In an article recently published, an international team lay out such an experiment.

Feb 1st, 2011

Read more

UV-transparent coating for image sensors

Image sensors as used in cell phones are partially color-blind. This is because of their coating, which prevents UV light from passing through. CMOS chips have as a result not been suitable for spectroscopy up to now. A new production process makes the coating transparent - and the sensors suitable for special applications.

Feb 1st, 2011

Read more

EU-funded team puts new semi-conductor material to the test

The electronic chips of the future might not be made of silicon or even graphene but of a material called molybdenite (MoS2). EU-funded research presented in the journal Nature Nanotechnology demonstrates that molybdenite is a highly effective semi-conductor that could be used to make transistors both smaller and more energy efficient.

Feb 1st, 2011

Read more

Call for papers: Dilemmas of choice. Responsibility in nanotechnology development

The Centre for Environmental Law Decisions and Corporate Ethical Certification (CIGA) at the University of Padua and the Institute for Technology Assessment and Systems Analysis (ITAS) at the Karlsruhe Institute of Technology, organize an international workshop titled Dilemmas of choice. Responsibility in nanotechnology development, which is aimed at presenting and debating contributions from different disciplines on several issues concerning the relationship between nanotechnology innovation and responsibility.

Feb 1st, 2011

Read more

Graphen anwendungsreif machen

An der Uni Bielefeld forschen die Physiker Prof. Dr. Armin Goelzhaeuser und Dr. Andrey Turchanin intensiv an dem vielversprechenden Nanomaterial mit besonderen elektronischen Eigenschaften.

Feb 1st, 2011

Read more

Novel cancer-targeting investigational nanoparticle receives FDA IND approval for human trial

Researchers at Memorial Sloan-Kettering Cancer Center's Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

Jan 31st, 2011

Read more

RSS Subscribe to our Nanotechnology News feed